Opioid Spotlight: Trump Announces Plans For More Spending As Congress Introduces Two Dozen Bills
Administration also plans to roll out slate of proposals to decrease drug prices and bring discounts to patients.
You may also be interested in...
US Centers for Medicare and Medicaid Services proposes a change to its reimbursement policies for non-opioid pain therapies which will benefit a single product: Pacira’s Exparel. However, the broader message for that company is mixed.
Some at patient-focused drug development meeting argue that cutting opioid use should not be considered treatment failure and that medications allowing controlled opioid use may be beneficial.
At House hearing on opioid epidemic, FDA Commissioner responds to range of legislative proposals, including those aimed at agency's drug approval and safety monitoring activities.